Elizabeth A Corker1, Alina Beldie2, Cecilia Brain3, Miro Jakovljevic4, Marek Jarema5, Oguz Karamustafalioglu6, Josef Marksteiner7, Pavel Mohr8, Dan Prelipceanu2, Anamaria Vasilache2, Margda Waern3, Norman Sartorius9, Graham Thornicroft10. 1. Health Service and Population Research Department, Institute of Psychiatry, King's College London, London, UK elizabeth.a.corker@kcl.ac.uk. 2. Al. Obregia Clinical Psychiatric Hospital, Bucharest, Romania. 3. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Nå Ut-teamet, Psychosis Clinic, Sahlgrenska University Hospital, Gothenburg, Sweden. 4. Department of Psychiatry, University Hospital Zagreb, Zagreb, Croatia. 5. Institute of Psychiatry and Neurology, Warszawa, Poland. 6. Clinic of Psychiatry, Sisli Etfal Education and Research Hospital, Istanbul, Turkey. 7. Psychiatrie I, LKH Rankweil, Rankweil, Austria. 8. Prague Psychiatric Center, Prague, Czech Republic. 9. Association for Mental Health Service Improvement, Geneva, Switzerland. 10. Health Service and Population Research Department, Institute of Psychiatry, King's College London, London, UK.
Abstract
AIM: To record and measure the nature and severity of stigma and discrimination experienced by people during a first episode of schizophrenia and those with a first episode of major depressive disorder. METHODS: The Discrimination and Stigma Scale (DISC-12) was used in a cross-sectional survey to elicit service user reports of anticipated and experienced discrimination by 150 people with a diagnosis of first-episode schizophrenia and 176 with a diagnosis of first-episode major depressive disorder in seven countries (Austria, Croatia, Czech Republic, Poland, Romania, Sweden and Turkey). RESULTS: Participants with a diagnosis of major depressive disorder reported discrimination in a greater number of life areas than those with schizophrenia, as rated by the total DISC-12 score (p = .03). With regard to specific life areas, participants with depression reported more discrimination in regard to neighbours, dating, education, marriage, religious activities, physical health and acting as a parent than participants with schizophrenia. Participants with schizophrenia reported more discrimination with regard to the police compared to participants with depression. CONCLUSION: Stigma and discrimination because of mental illness change in the course of the mental diseases. Future research may take a longitudinal perspective to better understand the beginnings of stigmatisation and its trajectory through the life course and to identify critical periods at which anti-stigma interventions can most effectively be applied.
AIM: To record and measure the nature and severity of stigma and discrimination experienced by people during a first episode of schizophrenia and those with a first episode of major depressive disorder. METHODS: The Discrimination and Stigma Scale (DISC-12) was used in a cross-sectional survey to elicit service user reports of anticipated and experienced discrimination by 150 people with a diagnosis of first-episode schizophrenia and 176 with a diagnosis of first-episode major depressive disorder in seven countries (Austria, Croatia, Czech Republic, Poland, Romania, Sweden and Turkey). RESULTS: Participants with a diagnosis of major depressive disorder reported discrimination in a greater number of life areas than those with schizophrenia, as rated by the total DISC-12 score (p = .03). With regard to specific life areas, participants with depression reported more discrimination in regard to neighbours, dating, education, marriage, religious activities, physical health and acting as a parent than participants with schizophrenia. Participants with schizophrenia reported more discrimination with regard to the police compared to participants with depression. CONCLUSION: Stigma and discrimination because of mental illness change in the course of the mental diseases. Future research may take a longitudinal perspective to better understand the beginnings of stigmatisation and its trajectory through the life course and to identify critical periods at which anti-stigma interventions can most effectively be applied.
Authors: Richard Newton; Alice Rouleau; Anna-Greta Nylander; Jean-Yves Loze; Henrike K Resemann; Sara Steeves; Benedicto Crespo-Facorro Journal: NPJ Schizophr Date: 2018-10-15
Authors: Terence V McCann; Michael Savic; Nyssa Ferguson; Alison Cheetham; Katrina Witt; Kate Emond; Emma Bosley; Karen Smith; Louise Roberts; Dan I Lubman Journal: BMJ Open Date: 2018-12-04 Impact factor: 2.692